Covid-19 and Parkinsonism, Volume 165 in the International Review in Neurobiology series, highlights new advances in the field with this new volume presenting interesting chapters that cover a variety of topics, including Parkinsonism associated with viral infections, Covid-19 and nervous system pathology: bench to bedside, Prevalence of Covid-19 in Parkinson’s Disease: acute settings and hospital, Covid-19 and Parkinson’s Disease: clinical features, long COVID, Smell deficits in Covid-19 and possible links with Parkinson’s Disease, Spotlight on non-motor symptoms and Covid-19, and a Summary of treatment paradigms in Parkinson’s Disease patients and Covid-19. Additional sections cover Covid-19 and Parkinson’s Disease: nursing care, vaccination, telemedicine services, impact on advanced therapies, Covid-19-induced parkinsonism: Real life phenoconversion cases, Loneliness and impact of lockdown on Parkinson’s Disease patients during the Covid-19 pandemic, Parkinson’s Disease and Covid-19: Impact of ethnicity and palliative care, and more.
Format:
CONTRIBUTORS: K Ray Chaudhuri
EAN: 9780323991735
COUNTRY: United Kingdom
PAGES:
WEIGHT: 630 g
HEIGHT: 229 cm
PUBLISHED BY: Elsevier Science & Technology
DATE PUBLISHED: 2022-09-22
CITY:
GENRE: MEDICAL / Neurology, SCIENCE / Life Sciences / Neuroscience
WIDTH: 152 cm
SPINE:
Book Themes:
Neurology and clinical neurophysiology, Neurosciences
Professor K Ray Chaudhuri is the Clinical Director of the National Parkinson Foundation International Centre of Excellence at King’s College and Kings College Hospital London, Lead of the King’s Neuroscience Research and Development unit and Chairman of the Movement Disorders Society Non-motor Study Group at Denmark Hill Campus in London.Professor Ray Chaudhuri also sits on the Nervous Systems Committee of the UK Department of Health, National Institute of Health Research, and serves as a member of the Scientific Programme Committee of the International Parkinson’s and Movement Disorders Society. In addition, he serves as a member of clinical advisory groups to Parkinson’s UK and the European Parkinson’s Disease Association. Having published over 350 papers and co-edited 4 books on PD and restless legs syndrome, Professor Ray Chaudhuri currently serves on the editorial board of numerous international journals including Basal Ganglia, the Journal of Parkinson’s Disease and is the editor in chief of the newly launched Nature Parkinson’s Journal. Professor K Ray Chaudhuri has particular expertise in non-motor aspects of PD focused on subtyping, sleep and pain. Attending neurologist at the National Institute of Neurology and Neurosurgery in Mexico City. Responsible of the Clinical Neurodegenerative Research Unit. Movement disorders training at the Hospital Clinic de Barcelona. Master in Sciences granted by the UNAM. Member of the National Research System (SNI level 3). Member of the National Academy of Medicine. Principal Professor of the Parkinson’s disease and Movement Disorders high specialty course recognized by the Health’s Ministry and the UNAM Angelo Antonini graduated in Medicine in 1986 and completed Neurology training in 1990 at the University of Rome “La Sapienza in Rome where he developed skills in neuropharmacology and movement disorders. After obtaining a scholarship in 1990, in 1991 he started a PhD in Neuroradiology with PET and MRI at the University of Zurich and the Institute of Physics Paul Scherrer in Villigen, Switzerland, which he completed in 1994. PET studies focused on the dopaminergic system, metabolic disorders and cerebral blood flow in healthy subjects, in Parkinson patients and with other movement disorders as well as psychiatric disorders.MRI studies focused on the study of signal T2 and its relationship with free iron as degeneration biomarkers. After one year as Post- Doc in Zurich, in October 1995 he continued his research at the Neuroimaging Laboratory of NY Shore University Hospital and was promoted to Assistant Professor at New University York. During this period, the research focused on the study of brain networks and their modulation with pharmacological and surgical interventions. In November 1997, he returned to Italy in Milan at the Parkinson Institute where he contributed to the development of a research centre for Parkinson’s disease and implemented clinical trials and functional surgery at the Department